ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,378.70
-0.61%
S&P ASX All Technology
3,885.10
-0.05%
Brent Oil
78.355
0.03%
US Dollar vs AUD
1.5977
0.22%
Bitcoin
101,809.93
-1.76%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Kronos Bio Inc (KRON) Share Price

Kronos Bio Inc

Kronos Bio Inc (KRON)

Kronos Strategy
1.00
0.0098
(0.99%)
Closed 23 January 8:00AM
Delayed by 15 minutes
1.00
0.00
( 0.00% )
Pre Market: 8:00PM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
1.00
Bid
1.00
Offer
1.09
Volume
-
0.00 Day's Range 0.00
0.69 52 Week Range 1.60
Market Cap
60.341M
Previous Close
1.00
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
298,228
Shares Outstanding
60,340,918
Dividend Yield
-
PE Ratio
-0.54
Earnings Per Share (EPS)
-1.87
Revenue
6.29M
Net Profit
-112.67M

About Kronos Bio Inc

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.kronosbio.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Kronos Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KRON. The last closing price for Kronos Bio was US$1. Over the last year, Kronos Bio shares have traded in a share price range of US$ 0.69 to US$ 1.60.

Kronos Bio currently has 60,340,918 shares in issue. The market capitalisation of Kronos Bio is US$60.34 million. Kronos Bio has a price to earnings ratio (PE ratio) of -0.54.

Ask ADVFN Intelligence (AI)

KRON Latest News

More News

California Biotech Stock Bid Up Prior To Opening Bell On Major Announcement

A California-based biotech company is already stealing the show during Wednesday’s premarket after the company announced a CEO transition and an estimated 83% reduction in To read the full...

28 November 2024
AllPennyStocks.com

Kronos Bio Announces CEO Transition and Reduction in Force

– Norbert Bischofberger, Ph.D., is stepping down from his role as President & CEO – – Deborah Knobelman, Ph.D., COO & CFO, is named President & Interim CEO – SAN MATEO, Calif. and...

27 November 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

15 November 2024
Edgar (US Regulatory)

Kronos Bio Highlights Preclinical Data that Show p300 KAT Inhibitors Reduce Inflammation in an Oral Presentation at ACR Convergence 2024

– Preclinical data demonstrate the ability of p300 KAT inhibition to modulate multiple pro-inflammatory signaling pathways, including antibodies and cytokine production, in ex vivo and in vivo...

15 November 2024
GlobeNewswire Inc.

Form 8-K - Current report

14 November 2024
Edgar (US Regulatory)

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives

– Discontinuing development of istisociclib, a CDK9 inhibitor; benefit-risk profile in platinum-resistant high-grade serous ovarian cancer does not support further development – – Kronos Bio...

14 November 2024
GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933

08 November 2024
Edgar (US Regulatory)

Kronos Bio to Present Data at the ASH Annual Meeting from p300 KAT Inhibition Program in Multiple Myeloma

– Data demonstrates Kronos Bio's approach to targeting oncogenic transcription factors and the strong relationship between IRF4 and p300 in Multiple Myeloma – – Poster presentation to take place...

06 November 2024
GlobeNewswire Inc.

Kronos Bio Data Presentation at EORTC-NCI-AACR Symposium Highlights the Importance of p300 KAT Inhibition in HPV-Driven Tumors

SAN MATEO, Calif., and CAMBRIDGE, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and...

23 October 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

16 October 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.011.01010101010.991.030.95041919190.9986338CS
40.055.263157894740.951.030.89023317370.95443231CS
120.05145.418511490620.94861.090.82982280.94196785CS
26-0.26-20.63492063491.261.460.81779900.96614327CS
52-0.09-8.256880733941.091.60.692879671.03894873CS
156-8.53-89.50682056669.5310.940.692952602.42798746CS
260-27.29-96.465182043128.2939.6050.692802668.10928167CS

KRON - Frequently Asked Questions (FAQ)

What is the current Kronos Bio share price?
The current share price of Kronos Bio is US$ 1.00
How many Kronos Bio shares are in issue?
Kronos Bio has 60,340,918 shares in issue
What is the market cap of Kronos Bio?
The market capitalisation of Kronos Bio is USD 60.34M
What is the 1 year trading range for Kronos Bio share price?
Kronos Bio has traded in the range of US$ 0.69 to US$ 1.60 during the past year
What is the PE ratio of Kronos Bio?
The price to earnings ratio of Kronos Bio is -0.54
What is the cash to sales ratio of Kronos Bio?
The cash to sales ratio of Kronos Bio is 9.6
What is the reporting currency for Kronos Bio?
Kronos Bio reports financial results in USD
What is the latest annual turnover for Kronos Bio?
The latest annual turnover of Kronos Bio is USD 6.29M
What is the latest annual profit for Kronos Bio?
The latest annual profit of Kronos Bio is USD -112.67M
What is the registered address of Kronos Bio?
The registered address for Kronos Bio is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Kronos Bio website address?
The website address for Kronos Bio is www.kronosbio.com
Which industry sector does Kronos Bio operate in?
Kronos Bio operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DGNXDiginex Ltd
 18.21
(142.80%)
319.32k
FSEAFirst Seacoast Bancorp Inc
US$ 15.90
(59.00%)
6
BBGIBeasley Broadcast Group Inc
US$ 13.31
(58.45%)
14
FBNCFirst Bancorp
US$ 67.00
(52.62%)
205
CFSBCFSB Bancorp Inc
US$ 11.25
(50.00%)
40
CVBFCVB Financial Corporation
US$ 11.00
(-46.83%)
203
CPBICentral Plains Bancshares Inc
US$ 10.01
(-31.67%)
7
DCOMDime Community Bancshares Inc
US$ 22.00
(-30.71%)
200
TSBKTimberland Bancorp Inc
US$ 21.01
(-27.63%)
12
XNCRXencor Inc
US$ 15.01
(-27.38%)
1
KOPNKopin Corporation
US$ 2.14
(45.58%)
7.43M
HEPAHepion Pharmaceuticals Inc
US$ 0.1599
(18.44%)
4.39M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.3289
(3.10%)
3.93M
ASSTAsset Entities Inc
US$ 1.64
(20.59%)
3.4M
SHViShares Short Treasury Bond ETF
US$ 110.38
(0.02%)
3.37M

KRON Discussion

View Posts
PonkenPlonken PonkenPlonken 3 weeks ago
soon
👍️0
Monksdream Monksdream 5 months ago
KRON under $2
👍️0
Monksdream Monksdream 6 months ago
KRON under $2
👍️0
PonkenPlonken PonkenPlonken 6 months ago
Check CEO CV, super smart man that helped build Gilead before moving on to work on KRON. Recently he bought 8 million shares of common stock. I think its time to listen to whats being said. Chart sees clean breakout.

Probably the only promising CDK9 out there
👍️0
glenn1919 glenn1919 6 months ago
KRON.................................https://stockcharts.com/h-sc/ui?s=KRON&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 months ago
KRON under $2
👍️0
glenn1919 glenn1919 10 months ago
KRON.................................https://stockcharts.com/h-sc/ui?s=KRON&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 10 months ago
KRON under $2
👍️0
glenn1919 glenn1919 11 months ago
KRON....................................https://stockcharts.com/h-sc/ui?s=KRON&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 months ago
KRON under $2
👍️0
Monksdream Monksdream 1 year ago
KRON new 52 week low
👍️0
Monksdream Monksdream 1 year ago
KRON new 52 week low
👍️0

Your Recent History

NASDAQ
KRON
Kronos Bio
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads